BIRC5 and breast carcinoma: Apart from this, survivin expression, an apoptosis inhibitor and proliferation promotor [42, 43], showed slight but insignificant decreasing values (with exception of the mammary carcinoma derived cell line DT14/06T) following DCA treatment and supports the hypothesis that DCA has no pro-apoptotic effects on canine mammary cancer cells.